Patent Assignment
Reel/Frame 059193/0177
Change of Name
Recorded: 2022-02-24
Pages: 5
Assignor
THRESHOLD PHARMACEUTICALS, INC.
Executed: 2017-08-01
Assignee
MOLECULAR TEMPLATES, INC.
9301 AMBERGLEN BLVD, SUITE100, AUSTIN, TEXAS, 78729
Covered Property
(1)
Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer
Application:
15/998,702 →
Publication:
US 2019/0060275
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 2, 2021
From: MOLECULAR TEMPLATES, INC.
To: IMMUNOGENESIS, INC.
Reel/Frame 056414/0241 →
Assignment of Assignor's Interest
Feb 24, 2022
From: HART, CHARLES; CURD, JOHN; KROLL, STEWART; SUN, JESSICA
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 059091/0839 →
Assignment of Assignor's Interest
Oct 26, 2022
From: MOLECULAR TEMPLATES, INC.
To: IMMUNOGENESIS, INC.
Reel/Frame 061545/0067 →